Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
'Craze' Sports Supplement Contains Meth-Like Substance: Report
Two popular supplements appear to contain a chemical similar to
methamphetamine, according to an investigation by
The products include the Craze pre-workout powder, made by New
York-based Driven Sports, and a pill called Detonate, marketed as a
diet aid by New Jersey-based Gaspari Nutrition. Both are marketed
as containing only natural ingredients, the newspaper said, but its
own analysis conducted in both the United States and South Korea
found they contained an amphetamine-like compound called
"These are basically brand-new drugs that are being designed in clandestine laboratories where there's absolutely no guarantee of quality control," Pieter Cohen, an assistant professor at Harvard Medical School and a co-author of the analysis of the Craze samples, told USA Today.
"It has never been studied in the human body," Cohen said. "Yes, it might make you feel better or have you more pumped up in your workout, but the risks you might be putting your body under of heart attack and stroke are completely unknown."
The newspaper noted that Craze was named the "New Supplement of
the Year" by Bodybuilding.com. While Walmart and many online
retailers have stopped selling the supplement, it continues to be
available on some websites and the GNC health supplement chain of
A lawyer representing Driven Sports declined to comment on the
latest findings. "We have previously provided
USA Todaywith a plethora of data from a DEA Certified Lab
indicating the absence of any amphetamine-like compound in Craze,"
attorney Marc Ullman said in an e-mail to the newspaper. "In light
USA Today's decision to ignore the data we have provided, we
respectfully decline to comment for your story."
Officials at Gaspari Nutrition did not respond to the
newspaper's requests for comment.
Cohen said his team informed the U.S. Food and Drug
Administration in May about discovering the amphetamine-like
compound in Craze. Due to the federal government shutdown,
officials at the FDA could not be reached for comment on the latest
The analysis of the Craze samples is being published Oct. 14 in
the peer-reviewed scientific journal
Drug Testing and Analysis.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.